References:
- Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY,
Strober W, Lenardo MJ, Puck JM. Dominant interfering Fas gene
mutations impair apoptosis in a human autoimmune lymphoproliferative
syndrome. Cell. 1995 Jun 16;81(6):935-46.
- Rieux-Laucat, F., Le Deist, F. & Fischer, A. Autoimmune
lymphoproliferative syndromes: genetic defects of apoptosis
pathways. Cell Death Differ 10 , 124–133 (2003).
- Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than
a FAScinating disease. F1000Res. 2017 Nov 1;6:1928.
- Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, Neven B, Schaffner C,
Ducrot N, Arkwright PD, Bader-Meunier B, Barbot J, Blanche S, Casanova
JL, Debré M, Ferster A, Fieschi C, Florkin B, Galambrun C, Hermine O,
Lambotte O, Solary E, Thomas C, Le Deist F, Picard C, Fischer A,
Rieux-Laucat F. FAS-L, IL-10, and double-negative CD4- CD8- TCR
alpha/beta+ T cells are reliable markers of autoimmune
lymphoproliferative syndrome (ALPS) associated with FAS loss of
function. Blood. 2009 Mar 26;113(13):3027-30.
- Magerus-Chatinet A, Neven B, Stolzenberg MC, Daussy C, Arkwright PD,
Lanzarotti N, Schaffner C, Cluet-Dennetiere S, Haerynck F, Michel G,
Bole-Feysot C, Zarhrate M, Radford-Weiss I, Romana SP, Picard C,
Fischer A, Rieux-Laucat F. Onset of autoimmune lymphoproliferative
syndrome (ALPS) in humans as a consequence of genetic defect
accumulation. J Clin Invest. 2011 Jan;121(1):106-12.
- Price S, Shaw PA, Seitz A, et al.: Natural history of autoimmune
lymphoproliferative syndrome associated with FAS gene
mutations. Blood. 2014;123(13):1989–99.
- Bleesing JJH, Nagaraj CB, Zhang K. Autoimmune Lymphoproliferative
Syndrome. 2006 Sep 14 [Updated 2017 Aug 24]. In: Adam MP, Everman
DB, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle
(WA): University of Washington, Seattle; 1993-2022. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK1108/.
- Singh R, Pradhan V, Patwardhan M, Ghosh K. APO-1/Fas gene: Structural
and functional characteristics in systemic lupus erythematosus and
other autoimmune diseases. Indian J Hum Genet. 2009;15(3):98-102.
- Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo
MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK. Revised
diagnostic criteria and classification for the autoimmune
lymphoproliferative syndrome (ALPS): report from the 2009 NIH
International Workshop. Blood. 2010 Oct 7;116(14):e35-40.
- Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus
histiocytosis with massive lymphadenopathy in patients with autoimmune
lymphoproliferative syndrome. Am J Surg Pathol .
2005;29(7):903-911.
- Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, Jackson CE,
Puck JM, Dale J, Straus SE, Peter ME, Krammer PH, Fesik S, Lenardo MJ.
Defective CD95/APO-1/Fas signal complex formation in the human
autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U
S A. 1999 Apr 13;96(8):4552-7.
- Gu H, Chen Z, Ma J, Ma J, Fu L, Zhang R, Wang T, Wu R. Case report:
Effectiveness of sirolimus in a de novo FAS mutation leading to
autoimmune lymphoproliferative syndrome-FAS and elevated DNT/Treg
ratio. Front Pediatr. 2022 Jul 28;10:868193.
- Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying
autoimmune lymphoproliferative syndrome in children with Evans
syndrome: a multi-institutional study. Blood. 2010 Mar
18;115(11):2142-5.
- Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in
families with autoimmune lymphoproliferative syndrome with germline
Fas mutations and defective lymphocyte apoptosis. Blood.
2001;98(1):194-200. Blood. 2017 Jul 13;130(2):232.